01 7Bosulif
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 365
2018 Revenue in Millions : 296
Growth (%) : 23
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 450
2019 Revenue in Millions : 365
Growth (%) : 23
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 540
2020 Revenue in Millions : 450
Growth (%) : 20
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 575
2021 Revenue in Millions : 540
Growth (%) : 6
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 645
2022 Revenue in Millions : 575
Growth (%) : 12
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 233
2016 Revenue in Millions : 167
Growth (%) : 40
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 375
2017 Revenue in Millions : 233
Growth (%) : 61%
LOOKING FOR A SUPPLIER?
